Serum precipitins in pulmonary aspergillosis: preliminary results

S Charoenratanakul1, A Chaiprasert, C Voramist

  • 1Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

The Ceylon Medical Journal
|September 1, 1992
PubMed

Insights

An immunodiffusion test aids in diagnosing pulmonary aspergillosis. This fungal infection test showed high accuracy in mycetoma cases and was negative in healthy controls.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pulmonary Medicine

Background:

  • Definitive diagnosis of pulmonary aspergillosis remains challenging.
  • Confirmative evidence of active fungal infection is crucial for effective treatment.
  • Pulmonary aspergillosis encompasses various forms, including mycetoma, allergic bronchopulmonary aspergillosis, and invasive aspergillosis.

Purpose of the Study:

  • To evaluate the efficacy of an immunodiffusion test in supporting the diagnosis of pulmonary aspergillosis.
  • To assess the test's performance across different clinical presentations of fungal lung infections.

Main Methods:

  • An immunodiffusion test was performed on 36 patients diagnosed with pulmonary aspergillosis.
  • Control groups included 133 patients with non-fungal diseases and 134 healthy volunteers.
  • The test's positivity rate was analyzed for different types of pulmonary aspergillosis.

Main Results:

  • The immunodiffusion test yielded positive results in 92.3% of mycetoma cases.
  • Positive results were observed in 50% of allergic bronchopulmonary aspergillosis cases.
  • The test was positive in 25% of invasive aspergillosis cases and negative in all control subjects.

Conclusions:

  • The immunodiffusion test demonstrates significant efficacy in supporting the diagnosis of pulmonary aspergillosis.
  • The test's performance varies depending on the specific clinical form of the fungal infection.
  • This diagnostic tool can help differentiate fungal lung infections from other conditions.